61 related articles for article (PubMed ID: 34516350)
21. Protein tyrosine phosphatase, receptor type B is a potential biomarker and facilitates cervical cancer metastasis via epithelial-mesenchymal transition.
Huang ZY; Liao PJ; Liu YX; Zhong M; Sun AH; Jiang XC; Wang XP; Zhang M
Bioengineered; 2021 Dec; 12(1):5739-5748. PubMed ID: 34516350
[TBL] [Abstract][Full Text] [Related]
22. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
[TBL] [Abstract][Full Text] [Related]
23. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
Zhang X; Liu S; Zhu Y
Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA
Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
[TBL] [Abstract][Full Text] [Related]
25. A novel ferroptosis-related gene signature for predicting outcomes in cervical cancer.
Qi X; Fu Y; Sheng J; Zhang M; Zhang M; Wang Y; Li G
Bioengineered; 2021 Dec; 12(1):1813-1825. PubMed ID: 33989111
[TBL] [Abstract][Full Text] [Related]
26. PSMD11, PTPRM and PTPRB as novel biomarkers of pancreatic cancer progression.
Sahni S; Krisp C; Molloy MP; Nahm C; Maloney S; Gillson J; Gill AJ; Samra J; Mittal A
Biochim Biophys Acta Gen Subj; 2020 Nov; 1864(11):129682. PubMed ID: 32663515
[TBL] [Abstract][Full Text] [Related]
27. A Review of Cervical Cancer: Incidence and Disparities.
Buskwofie A; David-West G; Clare CA
J Natl Med Assoc; 2020 Apr; 112(2):229-232. PubMed ID: 32278478
[TBL] [Abstract][Full Text] [Related]
28. Incidence and mortality from cervical cancer and other malignancies after treatment of cervical intraepithelial neoplasia: a systematic review and meta-analysis of the literature.
Kalliala I; Athanasiou A; Veroniki AA; Salanti G; Efthimiou O; Raftis N; Bowden S; Paraskevaidi M; Aro K; Arbyn M; Bennett P; Nieminen P; Paraskevaidis E; Kyrgiou M
Ann Oncol; 2020 Feb; 31(2):213-227. PubMed ID: 31959338
[TBL] [Abstract][Full Text] [Related]
29. Targeting survivin sensitizes cervical cancer cells to radiation treatment.
Zhou J; Guo X; Chen W; Wang L; Jin Y
Bioengineered; 2020 Dec; 11(1):130-140. PubMed ID: 31959045
[TBL] [Abstract][Full Text] [Related]
30. miR-624-5p promoted tumorigenesis and metastasis by suppressing hippo signaling through targeting PTPRB in osteosarcoma cells.
Luo Y; Liu W; Tang P; Jiang D; Gu C; Huang Y; Gong F; Rong Y; Qian D; Chen J; Zhou Z; Zhao S; Wang J; Xu T; Wei Y; Yin G; Fan J; Cai W
J Exp Clin Cancer Res; 2019 Dec; 38(1):488. PubMed ID: 31829261
[TBL] [Abstract][Full Text] [Related]
31. Targeting the vascular-specific phosphatase PTPRB protects against retinal ganglion cell loss in a pre-clinical model of glaucoma.
Thomson BR; Carota IA; Souma T; Soman S; Vestweber D; Quaggin SE
Elife; 2019 Oct; 8():. PubMed ID: 31621585
[TBL] [Abstract][Full Text] [Related]
32. Lineage-negative lymphoma with a helper innate lymphoid cell phenotype.
Li M; Su X; Wang Y; Fan L; Chai J; Li P; Zhao D; Liu Y; Ma J; Wang K; Yan Q; Guo S; Jin B; Liang R; Wang Z
Virchows Arch; 2020 Feb; 476(2):285-293. PubMed ID: 31522287
[TBL] [Abstract][Full Text] [Related]
33. Whole-exome sequencing and RNA sequencing analyses of acinic cell carcinomas of the breast.
Beca F; Lee SSK; Pareja F; Da Cruz Paula A; Selenica P; Ferrando L; Gularte-Mérida R; Wen HY; Zhang H; Guerini-Rocco E; Rakha EA; Weigelt B; Reis-Filho JS
Histopathology; 2019 Dec; 75(6):931-937. PubMed ID: 31361912
[TBL] [Abstract][Full Text] [Related]
34. PTPRB promotes metastasis of colorectal carcinoma via inducing epithelial-mesenchymal transition.
Weng X; Chen W; Hu W; Xu K; Qi L; Chen J; Lu D; Shao Y; Zheng X; Ye C; Zheng S
Cell Death Dis; 2019 Apr; 10(5):352. PubMed ID: 31040266
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
